NL
DE
About this research group
Our bacterial research is primarily focused on the diagnostics of bacterial infections and antibiotic resistance. Antibiotic resistance has emerged in the last decade. This is mainly caused by global misuse and overuse of antibiotics and by transmission of resistance genes between bacteria.
Coordinated action
In hospitals, resistant bacteria are especially found in patients admitted to departments with high consumption of antibiotics, such as the ICU and the urology wards. Antimicrobial resistance increases the cost of health care with lengthier stays in hospitals and more intensive care required. read moreCoordinated action
In hospitals, resistant bacteria are especially found in patients admitted to departments with high consumption of antibiotics, such as the ICU and the urology wards. Antimicrobial resistance increases the cost of health care with lengthier stays in hospitals and more intensive care required.
Antibiotic resistance is emerging and spreading globally. Antimicrobial resistance is a complex problem that affects all of society and is driven by many interconnected factors. Coordinated action is required to minimize the emergence and spread of antimicrobial resistance.
Radboudumc researchers have been active in Vietnam, Tanzania, South Africa, Haiti, Mozambique, Ghana, Thailand and Bangladesh. We are involved in optimizing large-scale consumption of antibiotics and hospital infection control in these countries. An example is directed diagnostics using MALDI-TOF or the C-reactive protein (CRP) as a point-of-care marker for starting antibiotics in developing countries. Our research group collaborates with these countries to strengthen the evidence base and develop new responses to this global threat.
